Standard Diagnosis Criteria and Treatment Protocol for Hyperthyroidism
The standard diagnosis of hyperthyroidism requires biochemical confirmation with thyroid function tests showing low TSH and elevated free T4 and/or free T3 levels, followed by determination of etiology through antibody testing, imaging, and clinical assessment. 1
Diagnostic Criteria
Initial Laboratory Evaluation
- Thyroid Function Tests:
- First-line: TSH (thyroid-stimulating hormone)
- Second-line: Free T4 (thyroxine)
- Additional: Free T3 (triiodothyronine) in selected cases 2
- Interpretation:
- Overt hyperthyroidism: Suppressed TSH with elevated free T4 and/or T3
- Subclinical hyperthyroidism: Suppressed TSH with normal free T4 and T3 3
Etiological Diagnosis
Antibody Testing:
Imaging:
Clinical Assessment
Common Symptoms
- Anxiety, insomnia, palpitations
- Unintentional weight loss
- Heat intolerance
- Diarrhea
- Fatigue
- Tremors 3
Physical Examination Findings
- Tachycardia or atrial fibrillation
- Tremor
- Warm, moist skin
- Specific to Graves' disease:
- Diffusely enlarged thyroid (goiter)
- Exophthalmos (bulging eyes)
- Pretibial myxedema 3
Treatment Protocol
First-Line Treatment Options
Antithyroid Medications:
Methimazole (preferred):
- Initial dose: Based on severity of hyperthyroidism
- Monitor thyroid function tests 4-6 weeks after initiation
- Caution: Contraindicated in first trimester of pregnancy due to risk of congenital malformations 5
Propylthiouracil:
Radioactive Iodine Ablation:
Surgical Thyroidectomy:
- Consider for large goiters, suspicious nodules, or when other treatments are contraindicated
- Option for toxic nodular goiter 1
Adjunctive Therapy
- Beta-blockers (e.g., propranolol):
Treatment Selection Based on Etiology
Graves' Disease (accounts for 70% of cases):
Toxic Nodular Goiter (16% of cases):
- Preferred: Radioactive iodine or thyroidectomy 1
Thyroiditis (3% of cases):
- Supportive care for mild cases
- Steroids for severe cases 1
Monitoring During Treatment
- TSH and free T4 levels 6-8 weeks after initiating therapy or changing dosage 4
- Target: TSH within normal reference range (0.4-4.0 mIU/L) 4
- Monitor for medication side effects:
Special Considerations
Subclinical Hyperthyroidism
- Treatment recommended for:
- Patients >65 years
- Patients with persistent TSH <0.1 mIU/L
- Those at high risk for osteoporosis or cardiovascular disease 3
Pregnancy
- Switch from propylthiouracil to methimazole after first trimester 6
- Increase monitoring frequency during pregnancy
- Adjust medication to maintain the lowest effective dose 5, 6
Complications to Monitor
- Cardiac complications (atrial fibrillation, heart failure)
- Osteoporosis
- Thyroid storm (medical emergency requiring immediate intervention) 3
Common Pitfalls and Caveats
Euthyroid Sick Syndrome: Thyroid function tests may be misleading if performed during acute illness 4
Drug Interactions:
Treatment Monitoring: Failure to adjust antithyroid medication doses based on thyroid function tests can lead to under or overtreatment
Pregnancy Considerations: Failure to switch from methimazole to propylthiouracil in first trimester or vice versa after first trimester 5, 6